Georges Gemayel
Director · 4 filings · Latest: Jun 18, 2026
Disc Medicine, Inc.
SUPERNUS PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SUPN | Georges Gemayel | Director | Mar 6, 2026 | Sale | $53.00 | 8,787 | $465.7K | 27,277 | |
SUPN | Georges Gemayel | Director | Mar 6, 2026 | Option Exercise | $25.30 | 7,905 | $200.0K | 36,064 | |
SUPN | Georges Gemayel | Director | Mar 5, 2026 | Sale | $53.71 | 10,000 | $537.1K | 28,159 | |
SUPN | GEORGES GEMAYEL | — | Mar 6, 2026 | Proposed Sale | $53.01 | 8,787 | $465.8K | — | |
SUPN | GEORGES GEMAYEL | — | Mar 5, 2026 | Proposed Sale | $53.71 | 10,000 | $537.1K | — | |
SUPN | Georges Gemayel | Director | Feb 23, 2026 | Option Exercise | $12.98 | 15,000 | $194.7K | 33,684 | |
SUPN | GEORGES GEMAYEL | — | Nov 7, 2024 | Proposed Sale | $36.62 | 14,213 | $520.5K | — | |
SUPN | GEORGES GEMAYEL | — | Sep 13, 2024 | Proposed Sale | $31.33 | 13,886 | $435.0K | — | |
SUPN | GEORGES GEMAYEL | — | Nov 8, 2024 | Proposed Sale | $36.30 | 10,787 | $391.5K | — |